Lars Green

Member of the Novo Holdings Board since 2025 and appointed Chair of the Board in Nov. 2025. Member of the Novo Holdings Remuneration & Nomination Committee.

Lars Green was born in 1967 and is a Danish national.

Lars Green began his career as a finance graduate with Novo Nordisk and went on to serve in various leadership positions including group finance and key regional CFO roles in Japan and the U.S. before becoming Executive Vice President in Denmark. He later joined Novozymes as Executive Vice President and CFO, where he led initiatives to streamline the company’s strategy and enhance its commercial biotech focus. His cross-functional experience across the Novo Group brings valuable strategic alignment and continuity to the Novo Holdings Board.

Other Board Positions and Management Duties:

• Member of the Board of Directors of Novo Nordisk Foundation

• Member of the Board of Trustees of LEO Foundation and LEO Holdings A/S

• Member of the Board of directors and Chair of the Audit Committee of LEO Pharma A/S

• Member of the Board of directors and Chair of the Audit Committee of H. Lundbeck A/S

• Member of the Board of directors of Pharmacosmos A/S

• Member of the Board of directors of Nordic Storm A/S